XM does not provide services to residents of the United States of America.

CGI, Empire Company, Kinaxis



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>CANADA RESEARCH ROUNDUP-CGI, Empire Company, Kinaxis</title></head><body>

June 21 (Reuters) -Securities analysts revised their ratings and price targets on several Canadian companies, including CGI, Empire Company and Kinaxis, on Friday.

HIGHLIGHTS


* Alimentation Couche-Tard ATD.TO: Canaccord Genuity raises PT to C$87 from C$84

* Canadian Natural Resources Ltd CNQ.TO: Wells Fargo cuts PT to C$52 from C$56

* CGI Inc GIBa.TO: CIBC cuts to neutral from outperformer

* Empire Company Ltd EMPa.TO: Desjardins raises target price to C$40 from C$38

* Kinaxis Inc KXS.TO: CIBC cuts to neutral from outperformer


Following is a summary of research actions on Canadian companies reported by Reuters on Friday. Stock entries are in alphabetical order.

* Alimentation Couche-Tard ATD.TO: Canaccord Genuity raises PT to C$87 from C$84

* Aurora Cannabis Inc ACB.TO: ATB Capital Markets cuts target price to C$11 from C$12.5

* Canadian Natural Resources Ltd CNQ.TO: Wells Fargo cuts PT to C$52 from C$56

* CGI Inc GIBa.TO: CIBC cuts target price to C$151 from C$165

* CGI Inc GIBa.TO: CIBC cuts to neutral from outperformer

* Empire Company Ltd EMPa.TO: Desjardins raises target price to C$40 from C$38

* Empire Company Ltd EMPa.TO: National Bank of Canada raises target to C$41 from C$40

* Empire Company Ltd EMPa.TO: RBC cuts target price to C$41 from C$42

* Empire Company Ltd EMPa.TO: TD Cowen raises target price to C$38 from C$36

* First Quantum Minerals Ltd FM.TO: Morgan Stanley raises target to C$20.3 from C$19.8

* Innergex Renewable Energy Inc INE.TO: BMO raises PT to C$11 from C$9

* Kinaxis Inc KXS.TO: CIBC cuts target price to C$154 from C$180

* Kinaxis Inc KXS.TO: CIBC cuts to neutral from outperformer

* Lundin Mining Corp LUN.TO: Morgan Stanley raises target price to C$20.7 from C$20

* Well Health Technologies Corp WELL.TO: Raymond James raises PT to C$10 from C$9



(Compiled by Bengaluru Newsroom)

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.